• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Avient Corporation

    5/7/26 10:27:09 AM ET
    $AVNT
    Major Chemicals
    Industrials
    Get the next $AVNT alert in real time by email
    avnt-20260331
    0001122976false2026Q112/31http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURavnt:segmentavnt:company00011229762026-01-012026-03-3100011229762026-03-3100011229762025-01-012025-03-3100011229762025-12-3100011229762024-12-3100011229762025-03-310001122976us-gaap:CommonStockMember2025-12-310001122976us-gaap:TreasuryStockCommonMember2025-12-310001122976us-gaap:AdditionalPaidInCapitalMember2025-12-310001122976us-gaap:RetainedEarningsMember2025-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001122976us-gaap:ParentMember2025-12-310001122976us-gaap:NoncontrollingInterestMember2025-12-310001122976us-gaap:RetainedEarningsMember2026-01-012026-03-310001122976us-gaap:ParentMember2026-01-012026-03-310001122976us-gaap:NoncontrollingInterestMember2026-01-012026-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001122976us-gaap:TreasuryStockCommonMember2026-01-012026-03-310001122976us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001122976us-gaap:CommonStockMember2026-03-310001122976us-gaap:TreasuryStockCommonMember2026-03-310001122976us-gaap:AdditionalPaidInCapitalMember2026-03-310001122976us-gaap:RetainedEarningsMember2026-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001122976us-gaap:ParentMember2026-03-310001122976us-gaap:NoncontrollingInterestMember2026-03-310001122976us-gaap:CommonStockMember2024-12-310001122976us-gaap:TreasuryStockCommonMember2024-12-310001122976us-gaap:AdditionalPaidInCapitalMember2024-12-310001122976us-gaap:RetainedEarningsMember2024-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001122976us-gaap:ParentMember2024-12-310001122976us-gaap:NoncontrollingInterestMember2024-12-310001122976us-gaap:RetainedEarningsMember2025-01-012025-03-310001122976us-gaap:ParentMember2025-01-012025-03-310001122976us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001122976us-gaap:TreasuryStockCommonMember2025-01-012025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001122976us-gaap:CommonStockMember2025-03-310001122976us-gaap:TreasuryStockCommonMember2025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-03-310001122976us-gaap:RetainedEarningsMember2025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001122976us-gaap:ParentMember2025-03-310001122976us-gaap:NoncontrollingInterestMember2025-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2025-12-310001122976avnt:ColorAdditivesAndInksMember2025-12-310001122976avnt:SpecialtyEngineeredMaterialsMember2026-01-012026-03-310001122976avnt:ColorAdditivesAndInksMember2026-01-012026-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2026-03-310001122976avnt:ColorAdditivesAndInksMember2026-03-310001122976us-gaap:CustomerRelationshipsMember2026-03-310001122976avnt:PatentsTechnologyAndOtherMember2026-03-310001122976us-gaap:TradeNamesMember2026-03-310001122976us-gaap:CustomerRelationshipsMember2025-12-310001122976avnt:PatentsTechnologyAndOtherMember2025-12-310001122976us-gaap:TradeNamesMember2025-12-310001122976avnt:CloudBasedEnterpriseResourcePlanningSystemImpairmentAndOtherRelatedChargesMember2025-01-012025-03-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-01-012026-03-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-01-012026-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-01-012026-03-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-03-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2026-03-310001122976us-gaap:LandAndLandImprovementsMember2026-03-310001122976us-gaap:LandAndLandImprovementsMember2025-12-310001122976us-gaap:BuildingMember2026-03-310001122976us-gaap:BuildingMember2025-12-310001122976us-gaap:MachineryAndEquipmentMember2026-03-310001122976us-gaap:MachineryAndEquipmentMember2025-12-310001122976us-gaap:InternalRevenueServiceIRSMember2024-12-012024-12-310001122976us-gaap:InternalRevenueServiceIRSMember2025-03-042025-03-040001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2030Member2026-03-310001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2030Member2026-01-012026-03-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2026-03-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2026-01-012026-03-310001122976avnt:A5.75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2026-03-310001122976avnt:A5.75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2026-01-012026-03-310001122976avnt:A6.250SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2026-03-310001122976avnt:A6.250SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2026-01-012026-03-310001122976us-gaap:OtherDebtSecuritiesMember2026-03-310001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2030Member2025-12-310001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2030Member2025-01-012025-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-01-012025-12-310001122976avnt:A5.75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-12-310001122976avnt:A5.75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-01-012025-12-310001122976avnt:A6.250SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-12-310001122976avnt:A6.250SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-01-012025-12-310001122976us-gaap:OtherDebtSecuritiesMember2025-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976us-gaap:SecuredOvernightFinancingRateSofrMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976us-gaap:BaseRateMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976us-gaap:RevolvingCreditFacilityMemberavnt:JPMorganChaseBankCreditFacilityMemberus-gaap:LineOfCreditMember2025-06-120001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2026Member2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2026-01-012026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-01-012025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2026-01-012026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2026-01-012026-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2026-01-012026-03-310001122976us-gaap:CorporateNonSegmentMember2026-01-012026-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-01-012025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-01-012025-03-310001122976us-gaap:CorporateNonSegmentMember2025-01-012025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2026-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-12-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2026-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-12-310001122976us-gaap:CorporateNonSegmentMember2026-03-310001122976us-gaap:CorporateNonSegmentMember2025-12-310001122976avnt:CalvertCityMember2020-02-012020-02-2900011229762024-01-012024-12-310001122976avnt:CalvertCityMember2025-01-012025-12-310001122976avnt:CalvertCityMember2026-03-31


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ________________________________________________
    FORM 10-Q
    ________________________________________________
    (Mark One)
    ☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the quarterly period ended March 31, 2026
    OR    
     
    ☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the transition period from             to             .
    Commission file number 1-16091
     ________________________________________________
    AVIENT CORPORATION
    (Exact name of registrant as specified in its charter)
    ________________________________________________
    Ohio34-1730488
    (State or other jurisdiction(I.R.S. Employer Identification No.)
    of incorporation or organization)
    33587 Walker Road44012
    Avon Lake, Ohio
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (440) 930-1000
    Former name, former address and former fiscal year, if changed since last report: Not Applicable
    _______________________________________________

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Shares, par value $.01 per shareAVNTNew York Stock Exchange
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒    Yes   ☐ No
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒    Yes   ☐ No

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes   ☒  No

    The number of the registrant’s outstanding common shares, par value $.01 per share, as of March 31, 2026 was 91,710,167.

    AVIENT CORPORATION


    PART I — FINANCIAL INFORMATION
    ITEM 1. FINANCIAL STATEMENTS
    Avient Corporation
    Condensed Consolidated Statements of Income (Unaudited)
    (In millions, except per share data)
    Three Months Ended
    March 31,
     20262025
    Sales$847.4 $826.6 
    Cost of sales574.8 563.4 
    Gross margin272.6 263.2 
    Selling and administrative expense176.8 262.5 
    Operating income95.8 0.7 
    Interest expense, net(22.0)(26.9)
    Other expense, net(1.5)(0.4)
    Income (loss) before income taxes72.3 (26.6)
    Income tax (expense) benefit(16.5)6.7 
    Net income (loss)$55.8 $(19.9)
    Net income attributable to noncontrolling interests(0.1)(0.3)
    Net income (loss) attributable to Avient common shareholders$55.7 $(20.2)
    Earnings (loss) per share attributable to Avient common shareholders - Basic:$0.61 $(0.22)
    Earnings (loss) per share attributable to Avient common shareholders - Diluted:$0.61 $(0.22)
    Weighted-average shares used to compute earnings per common share:
    Basic91.7 91.5 
    Plus dilutive impact of share-based compensation0.2 — 
    Diluted91.9 91.5 
    Anti-dilutive share-based compensation awards1.8 2.5 
    Cash dividends declared per share of common stock$0.2750 $0.2700 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    1 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Statements of Comprehensive Income (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20262025
    Net income (loss)$55.8 $(19.9)
    Other comprehensive income, net of tax:
    Translation adjustments and related hedging instruments1.2 29.5 
    Total other comprehensive income1.2 29.5 
    Total comprehensive income57.0 9.6 
    Comprehensive income attributable to noncontrolling interests(0.1)(0.3)
    Comprehensive income attributable to Avient common shareholders$56.9 $9.3 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    2 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Balance Sheets
    (In millions)
    (Unaudited)
    March 31, 2026
    December 31, 2025
    ASSETS
    Current assets:
    Cash and cash equivalents$427.6 $510.5 
    Accounts receivable, net513.4 435.0 
    Inventories, net386.4 367.2 
    Other current assets96.5 88.2 
    Total current assets1,423.9 1,400.9 
    Property, net967.9 988.8 
    Goodwill1,739.2 1,757.6 
    Intangible assets, net1,447.4 1,492.4 
    Other non-current assets366.4 385.9 
    Total assets$5,944.8 $6,025.6 
    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current liabilities:
    Short-term and current portion of long-term debt$0.5 $0.5 
    Accounts payable426.1 410.0 
    Accrued expenses and other current liabilities376.5 435.8 
    Total current liabilities803.1 846.3 
    Non-current liabilities:
    Long-term debt1,924.0 1,922.6 
    Deferred income taxes280.5 285.7 
    Other non-current liabilities519.2 584.7 
    Total non-current liabilities2,723.7 2,793.0 
    SHAREHOLDERS' EQUITY
    Avient shareholders’ equity2,405.8 2,374.2 
    Noncontrolling interest12.2 12.1 
    Total equity2,418.0 2,386.3 
    Total liabilities and equity$5,944.8 $6,025.6 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    3 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Statements of Cash Flows (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20262025
    Operating activities
    Net income (loss)$55.8 $(19.9)
    Adjustments to reconcile net income (loss) to net cash used in operating activities:
    Depreciation and amortization47.9 45.3 
    Cloud-based enterprise resource planning system impairment— 71.6 
    Share-based compensation expense2.1 2.4 
    Changes in assets and liabilities:
    Increase in accounts receivable(83.7)(83.7)
    Increase in inventories(22.9)(20.3)
    Increase (decrease) in accounts payable20.0 (1.0)
    (Decrease) increase in restructuring obligations(4.7)2.5 
    Decrease in incentive accruals(24.8)(53.1)
    Environmental insurance recovery— 34.0 
    Accrued expenses and other assets and liabilities, net(24.2)(28.9)
    Net cash used in operating activities(34.5)(51.1)
    Investing activities
    Capital expenditures(19.0)(12.5)
    Net cash used in investing activities(19.0)(12.5)
    Financing activities
    Cash dividends paid(25.2)(24.7)
    Other financing activities(2.6)(3.6)
    Net cash used in financing activities(27.8)(28.3)
    Effect of exchange rate changes on cash and cash equivalents(1.6)3.4 
    Decrease in cash and cash equivalents(82.9)(88.5)
    Cash and cash equivalents at beginning of year510.5 544.5 
    Cash and cash equivalents at end of period$427.6 $456.0 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    4 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Statements of Shareholders' Equity (Unaudited)
    (In millions)

     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2026
    122.2 (30.6)$1.2 $1,542.4 $1,865.1 $(927.8)$(106.7)$2,374.2 $12.1 $2,386.3 
    Net income— — — — 55.7 — — 55.7 0.1 55.8 
    Other comprehensive income— — — — — — 1.2 1.2 — 1.2 
    Cash dividends declared -- $0.2750 per share
    — — — — (25.2)— — (25.2)— (25.2)
    Share-based compensation and exercise of awards— 0.1 — (1.3)— 1.2 — (0.1)— (0.1)
    Balance at March 31, 2026
    122.2 (30.5)$1.2 $1,541.1 $1,895.6 $(926.6)$(105.5)$2,405.8 $12.2 $2,418.0 

     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares  Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares  Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2025
    122.2 (30.8)$1.2 $1,537.5 $1,882.5 $(929.6)$(177.8)$2,313.8 $15.8 $2,329.6 
    Net loss— — — — (20.2)— — (20.2)0.3 (19.9)
    Other comprehensive income— — — — — — 29.5 29.5 — 29.5 
    Cash dividends declared -- $0.2700 per share
    — — — — (24.7)— — (24.7)— (24.7)
    Share-based compensation and exercise of awards— 0.1 — (1.2)— 1.1 — (0.1)— (0.1)
    Balance at March 31, 2025
    122.2 (30.7)$1.2 $1,536.3 $1,837.6 $(928.5)$(148.3)$2,298.3 $16.1 $2,314.4 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.


    5 AVIENT CORPORATION


    Avient Corporation
    Notes to Condensed Consolidated Financial Statements
    (Unaudited)
    Note 1 — BASIS OF PRESENTATION
    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Form 10-Q instructions and in the opinion of management contain all adjustments, including those that are normal, recurring and necessary to present fairly the financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the year ended December 31, 2025 of Avient Corporation. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results that may be attained in subsequent periods or for the year ending December 31, 2026.
    Accounting Standards Adopted
    In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (ASU 2025-05). This accounting standard provides a practical expedient allowing entities to assume that current conditions as of the balance sheet date remain unchanged over the remaining life of the asset when estimating expected credit losses. The Company adopted the ASU effective January 1, 2026 on a prospective basis. The adoption did not have a material impact on the Company's allowance for doubtful accounts.
    Accounting Standards Not Yet Adopted
    In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03). This accounting standard requires disaggregated income statement expense disclosures on an annual and interim basis, including inventory purchases, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains theses expenses. The standard also requires disclosure of total selling expenses on an annual and interim basis, and the definition of those expenses disclosed annually. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied prospectively or retrospectively. The Company is evaluating the impact of ASU 2024-03. As the standard will only impact its disclosures, there will be no material impact to the consolidated financial statements.
    In September 2025, the FASB issued ASU 2025-06, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40) Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06). This accounting standard changes when software project costs should be capitalized by removing all references to development stages and requiring costs to be capitalized when (1) the Company authorizes and commits to funding the software project and (2) it is probable the software project will be completed. The standard also requires additional annual and interim disclosures, including the capitalized software balance and accumulated amortization. ASU 2025-06 is effective for annual reporting periods, including interim reporting periods within those annual periods, beginning after December 15, 2027, with early adoption permitted and may be applied prospectively, retrospectively, or using a modified prospective transition approach. The Company is evaluating the impact of ASU 2025-06 and expects the standard will not have a material impact on the consolidated financial statements and related disclosures.


    6 AVIENT CORPORATION



    Note 2 — GOODWILL AND INTANGIBLE ASSETS
    Goodwill as of March 31, 2026 and December 31, 2025 and changes in the carrying amount of goodwill by segment were as follows:
    (In millions)Specialty Engineered MaterialsColor, Additives and InksTotal
    Balance at December 31, 2025$711.4 $1,046.2 $1,757.6 
    Currency translation(11.0)(7.4)(18.4)
    Balance at March 31, 2026$700.4 $1,038.8 $1,739.2 
    Indefinite and finite-lived intangible assets consisted of the following:

     As of March 31, 2026
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(278.9)$31.5 $478.8 
    Patents, technology and other847.0 (313.2)36.0 569.8 
    Indefinite-lived trade names362.8 — 36.0 398.8 
    Total$1,936.0 $(592.1)$103.5 $1,447.4 

     As of December 31, 2025
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(269.7)$39.2 $495.7 
    Patents, technology and other847.0 (301.4)46.2 591.8 
    Indefinite-lived trade names362.8 — 42.1 404.9 
    Total$1,936.0 $(571.1)$127.5 $1,492.4 


    7 AVIENT CORPORATION


    Note 3 — RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES
    In the first quarter of 2025, the Company completed a review of its cloud-based enterprise resource planning system, S/4HANA, including updated project timelines, cost incurred to date, required internal resources and expected costs to complete the initial site implementations, and the evolution of options that could provide better returns for shareholders. As a result of this review, the Company determined it would cease the ongoing development of S/4HANA.
    As a result of this decision, in the first quarter of 2025, the Company recognized a non-cash, pre-tax impairment charge of $71.6 million associated with capitalized implementation costs. The Company also recognized pre-tax charges of $14.7 million associated with unpaid contractual obligations for hosting fees. Further, the Company recognized charges of $2.8 million associated with severance actions resulting from the decision to cease development of S/4HANA. These charges are included in Selling and administrative expense within the Condensed Consolidated Statements of Income.
    Further restructuring charges in 2026 and 2025 were recognized associated with workforce reductions and plant closures. These actions have been taken as a result of productivity initiatives and organizational changes.
    A summary of all restructuring activity is shown below:
    (in millions)Workforce reductionsPlant closing and otherTotal
    Balance at January 1, 2025$10.1 $0.8 $10.9 
    Restructuring charges38.1 7.5 45.6 
    Payments, utilization and translation(12.9)(8.3)(21.2)
    Balance at December 31, 2025$35.3 $— $35.3 
    Restructuring charges0.8 3.2 4.0 
    Payments, utilization and translation(5.9)(3.2)(9.1)
    Balance at March 31, 2026$30.2 $— $30.2 
    These restructuring charges were included in Cost of sales and Selling and administrative expense.
    Note 4 — INVENTORIES, NET
    Components of Inventories, net are as follows:
    (In millions)As of March 31, 2026As of December 31, 2025
    Finished products$167.6 $162.7 
    Work in process23.6 23.7 
    Raw materials and supplies195.2 180.8 
    Inventories, net$386.4 $367.2 
    Note 5 — PROPERTY, NET
    Components of Property, net are as follows:
    (In millions)As of March 31, 2026As of December 31, 2025
    Land and land improvements$99.1 $100.8 
    Buildings451.1 455.6 
    Machinery and equipment1,375.4 1,382.5 
    Property, gross1,925.6 1,938.9 
    Less accumulated depreciation(957.7)(950.1)
    Property, net$967.9 $988.8 
    Note 6 — INCOME TAXES
    During the three months ended March 31, 2026, the Company’s effective tax rate of 22.8% was above the U.S federal rate of 21.0% primarily due to foreign earnings mix, U.S. global intangible low-taxed income (GILTI), and withholding taxes on foreign earnings. These unfavorable items were partially offset by U.S. research and development (R&D) credits, along with favorable foreign permanent items, most notably tax incentives associated with R&D.

    8 AVIENT CORPORATION


    During the three months ended March 31, 2025, the Company's effective tax rate resulted in a benefit of 25.2% as a result of pre-tax loss in the first quarter of 2025. The pre-tax loss was driven by the Company's cloud-based enterprise resource planning system impairment. The 25.2% income tax benefit was higher than the U.S. federal tax rate of 21.0% primarily due to the state and local tax benefit of the pre-tax loss.
    In December 2024, Avient received a Notice of Deficiency (Notice) from the U.S. Internal Revenue Service (IRS) proposing an adjustment to the 2019 tax year resulting from a disallowed capital loss. The proposed incremental tax associated with the Notice is $23.8 million plus estimated interest of $7.8 million. We contested the Notice by filing a petition in U.S. Tax Court on March 4, 2025. The IRS' answer to Avient's petition included an additional accuracy-related penalty of $4.8 million and is subject to interest. The Company believes that the proposed penalty is also without merit, and we intend to contest the penalty vigorously in U.S. Tax Court. However, there can be no assurance this dispute with the IRS will be resolved favorably. As of March 31, 2026, the Company has not recorded any income tax provision related to this matter; therefore an unfavorable ruling in U.S. Tax Court or settlement would adversely impact our effective tax rate and result in a cash tax payment.

    Note 7 — FINANCING ARRANGEMENTS
    Debt consists of the following instruments:
    As of March 31, 2026 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2030$— $— $— — %
    Senior secured term loan due 2029570.7 10.9 559.8 5.42 %
    7.125% senior notes due 2030
    725.0 5.9 719.1 7.125 %
    6.250% senior notes due 2031
    650.0 7.5 642.5 6.250 %
    Other Debt3.1 — 3.1 
    Total Debt1,948.8 24.3 1,924.5 
    Less short-term and current portion of long-term debt0.5 — 0.5 
    Total long-term debt, net of current portion$1,948.3 $24.3 $1,924.0 
    As of December 31, 2025 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2030$— $— $— — %
    Senior secured term loan due 2029570.7 11.7 559.0 6.01 %
    7.125% senior notes due 2030
    725.0 6.2 718.8 7.125 %
    6.250% senior notes due 2031
    650.0 7.9 642.1 6.250 %
    Other Debt3.2 — 3.2 
    Total Debt1,948.9 25.8 1,923.1 
    Less short-term and current portion of long-term debt0.5 — 0.5 
    Total long-term debt, net of current portion$1,948.4 $25.8 $1,922.6 

    On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.
    On June 12, 2025, the Company entered into a revolving credit agreement (the Revolving Credit Agreement) with various financial institutions as lenders, and JPMorgan Chase Bank, N.A., as administrative agent, which replaced our previous credit agreement set to mature in 2026. The Revolving Credit Agreement provides for a senior secured revolving credit facility of up to $500.0 million, which may be increased by up to $250.0 million, subject to certain conditions. Loans under the Revolving Credit Agreement will mature on June 12, 2030. The Revolving Credit Agreement contains representations and warranties, affirmative covenants, negative covenants and events of default that are substantially similar to those contained in the Company's existing term loan credit agreement.

    9 AVIENT CORPORATION


    During 2025, the Company made voluntary prepayments of $150.0 million on its senior secured term loan, which were applied to the principal installments in direct order of maturity. These prepayments were made without penalty or premium.
    As of March 31, 2026, we had no borrowings outstanding under the senior secured revolving credit facility.
    The agreements governing our senior secured revolving credit facility and our senior secured term loan, and the indentures and credit agreements governing our other debt, contain a number of customary financial and restrictive covenants that, among other things, limit our ability to: sell or otherwise transfer assets, including in a spin-off, incur additional debt or liens, consolidate or merge with any entity or transfer or sell all or substantially all of our assets, pay dividends or make certain other restricted payments, make investments, enter into transactions with affiliates, create dividend or other payment restrictions with respect to subsidiaries, make capital investments and alter the business we conduct. As of March 31, 2026, we were in compliance with all covenants.
    The estimated fair value of Avient’s debt instruments at March 31, 2026 and December 31, 2025 was $1,947.6 million and $1,967.1 million, respectively. The fair value of Avient’s debt instruments was estimated using prevailing market interest rates on debt with similar creditworthiness, terms and maturities and represent Level 2 measurements within the fair value hierarchy.
    Note 8 — DERIVATIVES AND HEDGING
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. We formally assess, designate and document, as a hedge of an underlying exposure, the qualifying derivative instrument that will be accounted for as an accounting hedge at inception. Additionally, we assess both at inception and at least quarterly thereafter, whether the financial instruments used in the hedging transaction are effective at offsetting changes in either the fair values or cash flows of the underlying exposures. In accordance with ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12), that ongoing assessment may be done qualitatively for highly effective relationships.
    Net Investment Hedge
    As a means of mitigating the impact of currency fluctuations on our Euro investments in foreign entities, we have executed cross-currency swaps, in which we pay fixed-rate interest in Euros and receive fixed-rate interest in U.S. dollars related to our future obligations to exchange Euros for U.S. dollars. We designated the cross-currency swaps as net investment hedges of our net investment in our European operations under ASU 2017-12 and applied the spot method to these hedges. The changes in fair value of the derivative instruments that are designated and qualify as hedges of net investments in foreign operations are recognized within Accumulated Other Comprehensive Income (Loss) (AOCI) to offset the changes in the values of the net investment being hedged. For the three months ended March 31, 2026, a gain of $54.6 million was recognized within translation adjustments in AOCI, net of tax, compared to losses of $44.3 million, net of tax, for the three months ended March 31, 2025. Included in Interest expense, net on the Condensed Consolidated Statements of Income is income of $9.0 million, for the three months ended March 31, 2026 and March 31, 2025, respectively, related to interest payments received from counterparties.
    All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. We determine the fair value of our derivatives based on valuation methods, which project future cash flows and discount the future amounts present value using market based observable inputs, including interest rate curves and foreign currency rates. The fair value of derivative financial instruments recognized in the Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 is as follows:
    As of March 31, 2026
    (In millions)Notional AmountOther current assetsOther non-current assetsOther current liabilitiesOther non-current liabilities
    Cross-currency swaps€2,575.4 $— $— $76.3 $233.0 
    (In millions)As of December 31, 2025
    Cross-currency swaps€2,575.4 $— $— $94.8 $286.1 


    10 AVIENT CORPORATION


    Note 9 — SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks and (2) Specialty Engineered Materials.
    Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer. Our CODM utilizes this measure as an input to determine appropriate resource allocations to our segments in the annual planning process and to periodically assess segment performance, primarily by evaluating actual results in comparison to the annual operating plan and forecast. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
    Financial information by reportable segment is as follows:
    (In millions)

    Three Months Ended March 31, 2026
    Color, Additives and InksSpecialty Engineered MaterialsCorporateConsolidated
    Total
    Sales$528.1 $320.2 $(0.9)$847.4 
    Cost of sales349.4 219.6 5.8 574.8 
    Selling and administrative expense97.3 53.2 26.3 176.8 
    Operating income$81.4 $47.4 $(33.0)$95.8 
    Interest expense, net(22.0)
    Other expense, net(1.5)
    Income before income taxes$72.3 



    Three Months Ended March 31, 2025
    Color, Additives and InksSpecialty Engineered MaterialsCorporateConsolidated
    Total
    Sales$519.7 $308.4 $(1.5)$826.6 
    Cost of sales346.6 210.6 6.2 563.4 
    Selling and administrative expense94.5 50.7 117.3 262.5 
    Operating income$78.6 $47.1 $(125.0)$0.7 
    Interest expense, net(26.9)
    Other expense, net(0.4)
    Loss before income taxes$(26.6)

    Three Months Ended
    March 31,
    20262025
    Depreciation and amortization:
    Color, Additives and Inks$22.4 $21.7 
    Specialty Engineered Materials22.6 21.5 
    Corporate2.9 2.1 
    Depreciation and amortization$47.9 $45.3 
    Capital expenditures:
    Color, Additives and Inks$5.4 $4.9 
    Specialty Engineered Materials9.4 6.8 
    Corporate4.2 0.8 
    Capital expenditures$19.0 $12.5 

    11 AVIENT CORPORATION


     Total Assets
    (In millions)As of March 31, 2026As of December 31, 2025
    Color, Additives and Inks$2,629.0 $2,602.4 
    Specialty Engineered Materials2,566.6 2,578.0 
    Corporate749.2 845.2 
    Total assets$5,944.8 $6,025.6 
    Note 10 — COMMITMENTS AND CONTINGENCIES
    We have been notified by federal and state environmental agencies and by private parties that we may be a potentially responsible party (PRP) in connection with the environmental investigation and remediation of certain sites. While government agencies frequently assert that PRPs are jointly and severally liable at these sites, in our experience, the interim and final allocations of liability costs are generally made based on the relative contribution of waste. We may also initiate corrective and preventive environmental projects of our own to support safe and lawful activities at our operations. We believe that compliance with current governmental regulations at all levels will not have a material adverse effect on our financial position, results of operations or cash flows.
    In September 2007, the United States District Court for the Western District of Kentucky (Court) in the case of Westlake Vinyls, Inc. v. Goodrich Corporation, et al., held that Avient must pay the remediation costs at the former Goodrich Corporation Calvert City facility (now largely owned and operated by Westlake Vinyls, Inc. (Westlake Vinyls)), together with certain defense costs of Goodrich Corporation. The rulings also provided that Avient can seek indemnification for contamination attributable to Westlake Vinyls. Following the rulings, the parties to the litigation agreed to settle all claims regarding past environmental costs incurred at the site. The settlement agreement provides a mechanism to pursue allocation of future remediation costs at the Calvert City site to Westlake Vinyls.
    The environmental obligation at the site arose as a result of an agreement between The B.F. Goodrich Company (n/k/a Goodrich Corporation) and our predecessor, The Geon Company, at the time of the initial public offering in 1993. Under the agreement, The Geon Company agreed to indemnify Goodrich Corporation for certain environmental costs at the site. Neither Avient nor The Geon Company ever operated the facility.
    Since 2009, Avient, along with respondents Westlake Vinyls and Goodrich Corporation, has worked with the United States Environmental Protection Agency (USEPA) to address the remedial activities at the site. The USEPA issued its Record of Decision (ROD) in September 2018. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial actions at the site. In February 2020, three companies signed the agreed Consent Decree and remedial action Work Plan, which received Federal Court approval in January 2021.
    In 2024, the Company finalized the design for the first phase of a barrier wall, as well as an updated remedial action timeline at the site, which resulted in charges of $19.8 million. Construction of the initial barrier wall was completed in the first quarter of 2025. Further, in 2025, the Company recognized charges of $21.3 million associated with incremental investigation and remedial design work deemed necessary based on results of ongoing findings at the site. This incremental work resulted in a two-year extension of the planned remedial action timeline, which also contributed to the charges. The remaining wall designs and construction are expected to be completed in phases through 2030. As the Company completes further design work and begins construction on the remaining sections of the barrier wall and other remedial components, the Company will update its accrual, which was $125.5 million as of March 31, 2026, for any new information as it becomes available.
    Total environmental accruals of $134.9 million and $141.2 million are reflected within Accrued expenses and other current liabilities and Other non-current liabilities in our Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025, respectively. These undiscounted accruals represent our best estimate of probable future costs that we can reasonably estimate, based upon currently available information and technology and how the remedy will be implemented. It is reasonably possible that we could incur additional costs in excess of the amount accrued, which could be material to our Condensed Consolidated Statements of Income. However, such additional costs cannot be currently estimated as they are dependent upon the results of future testing and findings during the execution of remedial design and remedial action, changes in the Calvert City construction timeline, changes in regulations, technology development, new information, newly discovered conditions and other factors that are not currently known.


    12 AVIENT CORPORATION


    During the three months ended March 31, 2026, Avient recognized costs of $3.9 million, primarily associated with the ongoing remedial design and remedial action at Calvert City, compared to costs of $4.9 million recognized during the three months ended March 31, 2025. These costs are recognized in Cost of Sales within the Condensed Consolidated Statements of Income.
    We received $34.0 million of cash associated with Calvert City insurance recoveries in the first quarter of 2025. The associated gain was recognized in the fourth quarter of 2024. Further insurance recoveries, if any, related to remedial activities at the Calvert City site are expected to be immaterial.
    Avient is subject to a broad range of claims, administrative and legal proceedings such as lawsuits that relate to contractual allegations, tax audits, product claims, personal injuries and employment related matters. Although it is not possible to predict with certainty the outcome or cost of these matters, the Company believes our current reserves are appropriate and these matters will not have a material adverse effect on the condensed consolidated financial statements.


    13 AVIENT CORPORATION


    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    Our Business
    We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive solutions. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing sites, research and development facilities, design centers and warehouses around the globe. We provide value to our customers through our ability to link our knowledge of polymers and materials science with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of materials. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Results of Operations — The three months ended March 31, 2026 compared to the three months ended March 31, 2025:
     
    Three Months Ended
    March 31,
    Variances — Favorable (Unfavorable)
    (Dollars in millions, except per share data)20262025Change%
    Change
    Sales$847.4 $826.6 $20.8 2.5 %
    Cost of sales574.8 563.4 (11.4)(2.0)%
    Gross margin272.6 263.2 9.4 3.6 %
    Selling and administrative expense176.8 262.5 85.7 32.6 %
    Operating income95.8 0.7 95.1 nm
    Interest expense, net(22.0)(26.9)4.9 18.2 %
    Other expense, net(1.5)(0.4)(1.1)nm
    Income (loss) before income taxes72.3 (26.6)98.9 371.8 %
    Income tax (expense) benefit(16.5)6.7 (23.2)(346.3)%
    Net income (loss)55.8 (19.9)75.7 380.4 %
    Net income attributable to noncontrolling interests(0.1)(0.3)0.2 nm
    Net income (loss) attributable to Avient common shareholders$55.7 $(20.2)$75.9 375.7 %
    Earnings (loss) per share attributable to Avient common shareholders - Basic:$0.61 $(0.22)
    Earnings (loss) per share attributable to Avient common shareholders - Diluted:$0.61 $(0.22)
    nm - not meaningful
    Sales
    Sales increased $20.8 million, or 2.5%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Favorable foreign currency impacts were 4.6%, while sales, excluding the impacts of foreign exchange, decreased 2.0%. Sales increases within the building & construction, packaging and healthcare end markets were more than offset by declines in the consumer, transportation and industrial end markets.
    Gross Margin
    Gross margin as a percentage of sales was 32.2% for the three months ended March 31, 2026 compared to 31.8% for the three months ended March 31, 2025. The increase was primarily driven by cost savings from productivity and restructuring actions.
    Selling and administrative expense
    Selling and administrative expense decreased $85.7 million for the three months ended March 31, 2026, primarily driven by the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, in 2025, which resulted in an impairment charge of $71.6 million and additional charges of $14.7 million for unpaid contractual obligations for hosting fees.

    14 AVIENT CORPORATION


    Interest expense, net
    Interest expense, net decreased $4.9 million for the three months ended March 31, 2026, primarily driven by the benefit of reduced interest rates resulting from refinancing activity during 2025, in addition to prepayments on Avient's senior secured term loan totaling $150.0 million during 2025.
    Income taxes
    During the three months ended March 31, 2026, the Company’s effective tax rate of 22.8% was above the U.S federal rate of 21.0% primarily due to foreign earnings mix, U.S. global intangible low-taxed income (GILTI), and withholding taxes on foreign earnings. These unfavorable items were partially offset by U.S. research and development (R&D) credits, along with favorable foreign permanent items, most notably tax incentives associated with R&D.
    During the three months ended March 31, 2025, the Company's effective tax rate resulted in a benefit of 25.2% as a result of pre-tax loss in the first quarter of 2025. The pre-tax loss was driven by the Company's cloud-based enterprise resource planning system impairment. The 25.2% income tax benefit was higher than the U.S. federal tax rate of 21.0% primarily due to the state and local tax benefit of the pre-tax loss.
    SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials.
    Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer. Our CODM utilizes this measure as an input to determine appropriate resource allocations to our segments in the annual planning process and to periodically assess segment performance, primarily by evaluating actual results in comparison to the annual operating plan and forecast. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
    Sales and Operating Income — The three months ended March 31, 2026 compared to the three months ended March 31, 2025: 
     
    Three Months Ended
    March 31,
    Variances — Favorable
    (Unfavorable)
    (Dollars in millions)20262025Change%  Change
    Sales:
    Color, Additives and Inks$528.1 $519.7 $8.4 1.6 %
    Specialty Engineered Materials
    320.2 308.4 11.8 3.8 %
    Corporate(0.9)(1.5)0.6 nm
    Total sales$847.4 $826.6 $20.8 2.5 %
    Operating income:
    Color, Additives and Inks$81.4 $78.6 $2.8 3.6 %
    Specialty Engineered Materials
    47.4 47.1 0.3 0.6 %
    Corporate(33.0)(125.0)92.0 73.6 %
    Total operating income$95.8 $0.7 $95.1 nm
    Color, Additives and Inks
    Sales increased $8.4 million, or 1.6%, in the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Favorable foreign currency impacts were 5.1%, while sales, excluding the impacts of foreign exchange, decreased 3.5%. The sales decrease was primarily within the consumer, building & construction and transportation end markets, partially offset by a sales increase in the healthcare end market.
    Operating income increased $2.8 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The increase was primarily driven by cost savings from productivity and restructuring actions.

    15 AVIENT CORPORATION


    Specialty Engineered Materials
    Sales increased $11.8 million, or 3.8%, in the three months ended March 31, 2026 compared to the three months ended March 31, 2025. Favorable foreign currency impacts were 3.6%, while sales, excluding the impacts of foreign exchange, increased 0.2%. The sales increase was primarily within the building & construction and packaging end markets, partially offset by sales decreases in the consumer, industrial and transportation end markets.
    Operating income increased $0.3 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, primarily driven by higher sales.
    Corporate
    Corporate costs decreased $92.0 million for the three months ended March 31, 2026, primarily driven by the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, in 2025, which resulted in an impairment charge of $71.6 million and additional charges of $14.7 million for unpaid contractual obligations for hosting fees. Further, restructuring charges for the three months ended March 31, 2026 were $5.2 million lower, compared to the three months ended March 31, 2025.
    Liquidity and Capital Resources
    Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.
    The following table summarizes our liquidity as of March 31, 2026 and December 31, 2025:
    (In millions)As of March 31, 2026As of December 31, 2025
    Cash and cash equivalents$427.6 $510.5 
    Revolving credit availability490.3 490.3 
    Liquidity$917.9 $1,000.8 
    As of March 31, 2026, approximately 78% of the Company’s cash and cash equivalents resided outside the United States.
    Expected sources of cash needed to satisfy cash requirements for the remainder of 2026 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if necessary. We believe that these sources will also provide sufficient liquidity to satisfy our expected uses of cash for at least the next twelve months and the foreseeable future thereafter. Expected uses of cash for the remainder of 2026 include interest payments, cash taxes, dividend payments, debt repayments, environmental remediation payments, restructuring payments and capital expenditures.
    Cash Flows
    The following describes the significant components of cash flows from operating, investing and financing activities for the three months ended March 31, 2026 and 2025.
    Operating Activities — Net cash used in operating activities decreased $16.6 million during the three months ended March 31, 2026 compared to the three months ended March 31, 2025, driven primarily by insurance proceeds of $34.0 million in 2025 for previously incurred losses at the Calvert City site partially offset by lower incentive compensation payments in 2026 associated with 2025 performance and lower working capital investment.
    Investing Activities — Net cash used in investing activities during the three months ended March 31, 2026 and 2025 of $19.0 million and $12.5 million, respectively, reflects the impact of capital expenditures.
    Financing Activities — Net cash used in financing activities for the three months ended March 31, 2026 and 2025 of $27.8 million and $28.3 million, respectively, primarily reflects dividend payments.


    16 AVIENT CORPORATION


    Debt
    As of March 31, 2026, aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:
    (In millions)
    2026$0.4 
    20270.4 
    20280.4 
    2029571.1 
    2030725.5 
    Thereafter651.0 
    Aggregate maturities$1,948.8 
    On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.
    On June 12, 2025, the Company entered into a revolving credit agreement (the Revolving Credit Agreement) with various financial institutions as lenders, and JPMorgan Chase Bank, N.A., as administrative agent, which replaced our previous credit agreement set to mature in 2026. The Revolving Credit Agreement provides for a senior secured revolving credit facility of up to $500.0 million, which may be increased by up to $250.0 million, subject to certain conditions. Loans under the Revolving Credit Agreement will mature on June 12, 2030. The Revolving Credit Agreement contains representations and warranties, affirmative covenants, negative covenants and events of default that are substantially similar to those contained in the Company's existing term loan credit agreement.
    During 2025, the Company made voluntary prepayments of $150.0 million on its senior secured term loan, which were applied to the principal installments in direct order of maturity. These prepayments were made without penalty or premium.
    As of March 31, 2026, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 7, Financing Arrangements, to the accompanying condensed consolidated financial statements.
    Derivatives and Hedging
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 8, Derivatives and Hedging, to the accompanying condensed consolidated financial statements.
    Material Cash Requirements
    We have future obligations under various contracts relating to debt and interest payments, operating leases, pension and post-retirement benefit plans, purchase obligations, restructuring payments and environmental remediation obligations. During the three months ended March 31, 2026, there were no material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2025.

    17 AVIENT CORPORATION


    CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
    In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
    •disruptions, uncertainty or volatility in the global credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
    •the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
    •disruptions or inefficiencies in our supply chain, logistics, or operations;
    •changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
    •changes to foreign trade policy, including new or increased tariffs and changing import/export regulations
    •fluctuations in raw material prices, quality and supply, and in energy prices and supply;
    •demand for our products and services;
    •production outages or material costs associated with scheduled or unscheduled maintenance programs;
    •unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
    •our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
    •information systems failures, cybersecurity breaches and cyberattacks;
    •our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness;
    •amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
    •other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, tariffs and any recessionary conditions; and
    •other factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 under Item 1A, “Risk Factors.”
    We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.


    18 AVIENT CORPORATION


    ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
    There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2025.

    ITEM 4. CONTROLS AND PROCEDURES
    Disclosure controls and procedures
    Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.
    Changes in internal control over financial reporting
    There were no changes in Avient’s internal control over financial reporting during the quarter ended March 31, 2026 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

    PART II — OTHER INFORMATION
    ITEM 1. LEGAL PROCEEDINGS
    Information regarding certain legal proceedings can be found in Note 10, Commitments and Contingencies, to the accompanying condensed consolidated financial statements and is incorporated by reference herein.

    ITEM 1A. RISK FACTORS
    We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. During the three months ended March 31, 2026, there have been no material changes to the risk factors that were previously disclosed.

    ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
    The table below sets forth information regarding the repurchase of shares of our common shares during the periods indicated.
    PeriodTotal Number of Shares PurchasedWeighted Average Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
    Maximum Number of Shares that May Yet be Purchased Under the Program (1)
    January 1 to January 31— $— — 4,957,472 
    February 1 to February 28— — — 4,957,472 
    March 1 to March 31— — — 4,957,472 
    Total— $— — 
    (1) Our Board of Directors approved a common share repurchase program authorizing Avient to purchase its common shares in August 2008, which share repurchase authorization has been subsequently increased from time to time. On December 9, 2020, we announced that we would increase our share buyback by an additional 5.0 million shares. As of March 31, 2026, approximately 5.0 million shares remained available for purchase under these authorizations, which have no expiration. Purchases of common shares may be made by open market purchases or privately negotiated transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.

    19 AVIENT CORPORATION


    ITEM 5. OTHER INFORMATION
    Trading Arrangements
    None of the Company's directors or officers (as defined in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended March 31, 2026.

    20 AVIENT CORPORATION


    ITEM 6. EXHIBITS
    EXHIBIT INDEX
    Exhibit No.Exhibit Description
    3.1
    Amended and Restated Articles of Incorporation of Avient Corporation (as amended through June 30, 2020) (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, SEC File No. 1-16091)
    3.2
    Avient Corporation Regulations (amended and restated effective May 11, 2023) (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed May 16, 2023, SEC File No. 1-16091)
    10.1†
    Form of 2026 Award Agreement under the Avient Corporation 2020 Equity and Incentive Compensation Plan (incorporated by reference to Exhibit 10.29 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, SEC File No. 1-16091)
    31.1**
    Certification of Ashish K. Khandpur, Chairman, President and Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    31.2**
    Certification of Jamie A. Beggs, Senior Vice President and Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Ashish K. Khandpur, Chairman, President and Chief Executive Officer
    32.2*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Jamie A. Beggs, Senior Vice President and Chief Financial Officer
    101.INSInline XBRL Instance Document
    101.SCHInline XBRL Taxonomy Extension Schema Document
    101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
    101.LABInline XBRL Taxonomy Extension Label Linkbase Document
    101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
    104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
    †Indicates management contract or compensatory plan, contract or arrangement in which one or more directors or executive officers of the Registrant may be participants
    *Furnished herewith.
    **Filed herewith.

    21 AVIENT CORPORATION


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
    May 7, 2026AVIENT CORPORATION
    /s/ Jamie A. Beggs
    Jamie A. Beggs
    Senior Vice President and Chief Financial Officer


    22 AVIENT CORPORATION
    Get the next $AVNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVNT

    DatePrice TargetRatingAnalyst
    3/4/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    9/17/2025$48.00Overweight
    KeyBanc Capital Markets
    3/14/2025$43.00Neutral
    Robert W. Baird
    2/18/2025$56.00Neutral → Buy
    Seaport Research Partners
    10/18/2024Buy → Neutral
    Seaport Research Partners
    8/7/2024$49.00 → $52.00Hold → Buy
    Deutsche Bank
    11/6/2023$46.00 → $37.00Buy → Hold
    Deutsche Bank
    2/16/2023$50.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $AVNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avient Announces Quarterly Dividend

    CLEVELAND, May 15, 2026 /PRNewswire/ -- The Board of Directors of Avient Corporation (NYSE:AVNT), an innovator of materials solutions, has declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per share on the common stock outstanding, to be paid on July 15, 2026, to stockholders of record on June 18, 2026. About AvientOur purpose at Avient Corporation (NYSE:AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world.  Our local touch and customer engagement, combined with our global presence, allo

    5/15/26 8:06:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Announces First Quarter 2026 Results

    First quarter sales grew 3% to $847 million, which includes a 5% favorable foreign exchange impact First quarter GAAP EPS of $0.61 compared to ($0.22) in the prior year quarterFirst quarter adjusted EPS of $0.83 exceeded guidance of $0.81; growth of 9% over the prior year quarter2026 full year adjusted EPS guidance range of $2.93 to $3.17, unchanged from prior guidanceCLEVELAND, May 7, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced its first quarter results for 2026. First quarter GAAP earnings per share (EPS) were $0.61 compared to ($0.22) in the prior year quarter. 

    5/7/26 6:22:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Announces Giuseppe (Joe) Di Salvo as Chief Financial Officer

    CLEVELAND, April 27, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, announced today that Giuseppe (Joe) Di Salvo has been promoted and named Senior Vice President and Chief Financial Officer, effective June 1, 2026. He will succeed Jamie A. Beggs, who will be leaving Avient June 1, 2026 to pursue other opportunities. Mr. Di Salvo brings 25 years of financial experience, including nearly 15 years at Avient, with extensive experience in investor relations, accounting, financial planning and analysis, and treasury. This diverse experience

    4/27/26 8:00:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    SEC Filings

    View All

    SEC Form SD filed by Avient Corporation

    SD - AVIENT CORP (0001122976) (Filer)

    6/1/26 4:48:01 PM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - AVIENT CORP (0001122976) (Filer)

    5/15/26 9:59:56 AM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Avient Corporation

    10-Q - AVIENT CORP (0001122976) (Filer)

    5/7/26 10:27:09 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Patterson Robert M bought $839,589 worth of shares (24,304 units at $34.55), increasing direct ownership by 4% to 610,897 units (SEC Form 4)

    4 - AVIENT CORP (0001122976) (Issuer)

    11/20/23 7:22:34 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SVP, Chief Financial Officer Di Salvo Giuseppe

    4 - AVIENT CORP (0001122976) (Issuer)

    6/2/26 2:39:23 PM ET
    $AVNT
    Major Chemicals
    Industrials

    New insider Di Salvo Giuseppe claimed ownership of 18,300 shares (SEC Form 3)

    3 - AVIENT CORP (0001122976) (Issuer)

    6/1/26 4:51:51 PM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form 4 filed by Wulfsohn William A

    4 - AVIENT CORP (0001122976) (Issuer)

    4/2/26 2:29:03 PM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avient downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Avient from Overweight to Sector Weight

    3/4/26 8:31:02 AM ET
    $AVNT
    Major Chemicals
    Industrials

    KeyBanc Capital Markets initiated coverage on Avient with a new price target

    KeyBanc Capital Markets initiated coverage of Avient with a rating of Overweight and set a new price target of $48.00

    9/17/25 7:58:06 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Robert W. Baird initiated coverage on Avient with a new price target

    Robert W. Baird initiated coverage of Avient with a rating of Neutral and set a new price target of $43.00

    3/14/25 7:30:35 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Leadership Updates

    Live Leadership Updates

    View All

    Avient Board of Directors Appoints Ashish K. Khandpur as Chairman of the Board

    CLEVELAND, May 14, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced that its Board of Directors has appointed Ashish K. Khandpur, Ph.D., Avient's President, Chief Executive Officer and Director, to serve in the additional role of Chairman of the Board, effective May 14, 2025. Dr. Khandpur succeeds Richard H. Fearon, who had served as Chairman of the Board of Directors since December 2023 and will continue to serve on the Board.  "Since joining Avient, Ashish has made an immediate impact, effectively leading the company i

    5/14/25 4:30:00 PM ET
    $AVNT
    Major Chemicals
    Industrials

    Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

    Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

    6/26/24 8:00:00 AM ET
    $A
    $ANIK
    $AVNT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical/Dental Instruments
    Health Care

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    $AVNT
    Financials

    Live finance-specific insights

    View All

    Avient Announces Quarterly Dividend

    CLEVELAND, May 15, 2026 /PRNewswire/ -- The Board of Directors of Avient Corporation (NYSE:AVNT), an innovator of materials solutions, has declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per share on the common stock outstanding, to be paid on July 15, 2026, to stockholders of record on June 18, 2026. About AvientOur purpose at Avient Corporation (NYSE:AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world.  Our local touch and customer engagement, combined with our global presence, allo

    5/15/26 8:06:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Announces First Quarter 2026 Results

    First quarter sales grew 3% to $847 million, which includes a 5% favorable foreign exchange impact First quarter GAAP EPS of $0.61 compared to ($0.22) in the prior year quarterFirst quarter adjusted EPS of $0.83 exceeded guidance of $0.81; growth of 9% over the prior year quarter2026 full year adjusted EPS guidance range of $2.93 to $3.17, unchanged from prior guidanceCLEVELAND, May 7, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced its first quarter results for 2026. First quarter GAAP earnings per share (EPS) were $0.61 compared to ($0.22) in the prior year quarter. 

    5/7/26 6:22:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient to Hold First Quarter 2026 Conference Call

    CLEVELAND, April 1, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, intends to release its first quarter 2026 earnings before the market opens on Thursday, May 7, 2026.  The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Thursday, May 7, 2026. The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here. Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the dial-in numbe

    4/1/26 7:00:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Avient Corporation (Amendment)

    SC 13G/A - AVIENT CORP (0001122976) (Subject)

    2/13/24 4:58:57 PM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Avient Corporation (Amendment)

    SC 13G/A - AVIENT CORP (0001122976) (Subject)

    2/9/24 7:50:56 AM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Avient Corporation

    SC 13G - AVIENT CORP (0001122976) (Subject)

    3/1/23 1:24:32 PM ET
    $AVNT
    Major Chemicals
    Industrials